Yacoubian TA - Search Results

1

14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse Models.

Gannon M, Wang B, Stringfellow SA, Quintin S, Mendoza I, Srikantha T, Roberts AC, Saito T, Saido TC, Roberson ED, Yacoubian TA. Gannon M, et al. Among authors: yacoubian ta. eNeuro. 2022 Jun 24;9(3):ENEURO.0368-21.2022. doi: 10.1523/ENEURO.0368-21.2022. Print 2022 May-Jun. eNeuro. 2022. PMID: 35697511 Free PMC article.

2

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.

Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Yacoubian TA, et al. Cell Death Dis. 2010;1(1):e2. doi: 10.1038/cddis.2009.4. Cell Death Dis. 2010. PMID: 21152247 Free PMC article.

3

Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins.

Slone SR, Lavalley N, McFerrin M, Wang B, Yacoubian TA. Slone SR, et al. Among authors: yacoubian ta. Neurobiol Dis. 2015 Jul;79:1-13. doi: 10.1016/j.nbd.2015.02.032. Epub 2015 Apr 8. Neurobiol Dis. 2015. PMID: 25862939 Free PMC article.

4

14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.

Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, Volpicelli-Daley LA, Whitaker RH, Placzek WJ, Becker K, Ma J, Yacoubian TA. Wang B, et al. Among authors: yacoubian ta. J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9. J Neurosci. 2018. PMID: 30093536 Free PMC article.

5

The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Underwood R, Wang B, Carico C, Whitaker RH, Placzek WJ, Yacoubian TA. Underwood R, et al. Among authors: yacoubian ta. J Biol Chem. 2020 Jun 5;295(23):8005-8016. doi: 10.1074/jbc.RA120.013337. Epub 2020 Apr 29. J Biol Chem. 2020. PMID: 32350025 Free PMC article.

6

007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents.

Gannon M, Yacoubian TA. Gannon M, et al. Among authors: yacoubian ta. Trends Pharmacol Sci. 2020 Jul;41(7):431-433. doi: 10.1016/j.tips.2020.05.001. Epub 2020 May 10. Trends Pharmacol Sci. 2020. PMID: 32402470 Free PMC article.

7

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.

Underwood R, Gannon M, Pathak A, Kapa N, Chandra S, Klop A, Yacoubian TA. Underwood R, et al. Among authors: yacoubian ta. Acta Neuropathol Commun. 2021 Jan 7;9(1):13. doi: 10.1186/s40478-020-01110-5. Acta Neuropathol Commun. 2021. PMID: 33413679 Free PMC article.

8

Transcriptional dysregulation in a transgenic model of Parkinson disease.

Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG. Yacoubian TA, et al. Neurobiol Dis. 2008 Mar;29(3):515-28. doi: 10.1016/j.nbd.2007.11.008. Epub 2007 Nov 28. Neurobiol Dis. 2008. PMID: 18191405 Free PMC article.

9

A neuroprotective role for angiogenin in models of Parkinson's disease.

Steidinger TU, Standaert DG, Yacoubian TA. Steidinger TU, et al. Among authors: yacoubian ta. J Neurochem. 2011 Feb;116(3):334-41. doi: 10.1111/j.1471-4159.2010.07112.x. Epub 2010 Dec 22. J Neurochem. 2011. PMID: 21091473 Free PMC article.

10

Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration.

Yacoubian TA, Standaert DG. Yacoubian TA, et al. Mov Disord. 2014 Mar;29(3):306. doi: 10.1002/mds.25766. Epub 2014 Jan 2. Mov Disord. 2014. PMID: 24395732 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters